Can nutrition influence circadian rhythm and heart rate variability?

被引:0
作者
Singh, RB [1 ]
Weydahl, A
Otsuka, K
Watanabe, Y
Yano, S
Mori, H
Ichimaru, Y
Mitsutake, G
Sato, Y
Fanghong, L
Zhao, ZY
Kartik, C
Gvozdjakova, A
机构
[1] Moradabad & Subharti Med Coll, Med Hosp, Meerut 244001, Uttar Pradesh, India
[2] Moradabad & Subharti Med Coll, Res Ctr, Meerut 244001, Uttar Pradesh, India
关键词
blood pressure variability; circadian rhythm; heart rate variability; nutrition;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Recent studies indicate that there is an interaction between biorhythms, the biological clock and triggers, which may be important in the pathogenesis of altered heart rate variability (HRV) and blood pressure variability (BPV). Circadian rhythms are under the influence of, and physiological variables are mediated by the activation of the adrenals, sympathetic/parasympathetic, hypothalamic and pituitary activity. Emotional stress, physical exertion, sleep deprivation and large fatty meals are major triggers of myocardial ischemia, angina, infarction, sudden cardiac death (SCID) and stroke. These events have been reported to exhibit a circadian variation with increased frequency in the second quarter of the day, which has also been observed in our studies on Indians. Recent studies indicate that altered HRV and BPV are also important in the pathogenesis and progression of heart failure, atheroma and thrombosis. Mediation via beta-blockers, oestrogens, n-3 fatty acids, vitamin E and coenzyme Q10 and fasting appears to have a beneficial influence whereas progestins, nifedipine, stress and exercise may have an adverse effect on HRV and BPV. We have reported that plasma levels of vitamin E and C are lower in the second quarter of the day than at other times, indicating their role in the pathogenesis of variability and cardiac events. Prospective studies also indicate that HRV and BPV are important and independent risk factors for cardiovascular events. However, no study has yet been conducted in patients with abnormal HRV and BPV in a randomized, placebo-controlled intervention trial to find out whether improvement in variability can cause a significant reduction in cardiovascular events. There is a need to study the role of n-3 fatty acids, coenzyme Q10, the effect of regular physical training, medication and ACE inhibitors in patients with abnormal HRV and BPV to demonstrate that improving variability can modulate cardiovascular events. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:115S / 124S
页数:10
相关论文
共 112 条
[51]  
HUIKURI HV, IN PRESS ARTERIOSCLE
[52]  
KAPLAN JR, 1987, J CARDIOVASC PHARM, V10, pS100, DOI 10.1097/00005344-198700102-00030
[53]   INHIBITION OF CORONARY ATHEROSCLEROSIS BY PROPRANOLOL IN BEHAVIORALLY PREDISPOSED MONKEYS FED AN ATHEROGENIC DIET [J].
KAPLAN, JR ;
MANUCK, SB ;
ADAMS, MR ;
WEINGAND, KW ;
CLARKSON, TB .
CIRCULATION, 1987, 76 (06) :1364-1372
[54]   DECREASED HEART-RATE-VARIABILITY AND ITS ASSOCIATION WITH INCREASED MORTALITY AFTER ACUTE MYOCARDIAL-INFARCTION [J].
KLEIGER, RE ;
MILLER, JP ;
BIGGER, JT ;
MOSS, AJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (04) :256-262
[55]   Effects of Spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure [J].
Korkmaz, ME ;
Müderrisoglu, H ;
Uluçam, M ;
Özin, B .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (06) :649-653
[56]   The bradycardic agent zatebradine enhances baroreflex sensitivity and heart rate variability in rats early after myocardial infarction [J].
Krüger, C ;
Landerer, V ;
Zugck, C ;
Ehmke, H ;
Kübler, W ;
Haass, M .
CARDIOVASCULAR RESEARCH, 2000, 45 (04) :900-912
[57]   CATECHOLAMINE-INDUCED AGGRAVATION OF AORTIC AND CORONARY ATHEROSCLEROSIS IN MONKEYS [J].
KUKREJA, RS ;
DATTA, BN ;
CHAKRAVARTI, RN .
ATHEROSCLEROSIS, 1981, 40 (3-4) :291-298
[58]  
KUMAGAI Y, 1992, CHRONOBIOLOGIA, V19, P43
[59]  
La Rovere MT, 1998, LANCET, V351, P478
[60]  
Lanza G A, 2000, Ital Heart J, V1, P221